Publication:
Evaluation of Clinical, Laboratory and Treatment Modalities of Pituitary Adenomas: Single Center Experience

dc.authorscopusid57394316700
dc.authorscopusid55537171600
dc.authorscopusid8572843800
dc.contributor.authorÖzdemi̇R Yavuz, A.
dc.contributor.authorKan, E.
dc.contributor.authorÇolak, R.
dc.date.accessioned2025-12-11T00:28:43Z
dc.date.issued2021
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Özdemi̇R Yavuz] Ayşe, Department of Internal Medicine, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Kan] Elif Kiliç, Department of Endocrinology, Ondokuz Mayis University, Medical School, Samsun, Turkey; [Çolak] Ramis, Department of Endocrinology, Ondokuz Mayis University, Medical School, Samsun, Turkeyen_US
dc.description.abstractPituitary adenomas are a group of disease with broad different clinical characteristics and complications. We aimed to present the data of patients being followed in a single center and discuss the pituitary adenomas based on the literature. Two hundred and twenty patients followed at Department of Endocrinology and Metabolism, Medical School of Ondokuz Mayis University, were included into study. Clinical characteristics, laboratory findings and treatment modalities were examined retrospectively. 59% of patients were female and 41% were male. Mean age during the diagnosis was 43.7 years. Pituitary macroadenomas were 62% of all adenomas and 73% of pituitary adenomas were functional. Among the functional adenomas, the most frequently seen types were prolactin-secreting adenoma and growth-hormone secreting adenoma. Treatment options were surgical treatment (67%), medical treatment (20%) and radiotherapy (7%). Post-operative complications were developed in 27 (13.2%) of patients. In patients with non-functional adenoma, the cure after surgery was detected as 19.6% and the remission after the surgery was detected as 8.9%. In this study, the characteristics of the pituitary adenomas were found similar to the literature in general. The early diagnosis of the disease has a significant importance in terms of treatment and the response to the treatment. © 2021 Ondokuz Mayis Universitesi. All rights reserved.en_US
dc.identifier.doi10.52142/omujecm.38.4.1
dc.identifier.endpage409en_US
dc.identifier.issn1309-4483
dc.identifier.issn1309-5129
dc.identifier.issue4en_US
dc.identifier.scopus2-s2.0-85122149019
dc.identifier.scopusqualityQ4
dc.identifier.startpage404en_US
dc.identifier.urihttps://doi.org/10.52142/omujecm.38.4.1
dc.identifier.urihttps://hdl.handle.net/20.500.12712/36569
dc.identifier.volume38en_US
dc.language.isoenen_US
dc.publisherOndokuz Mayis Universitesien_US
dc.relation.ispartofJournal of Experimental and Clinical Medicine (Turkey)en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectAcromegalyen_US
dc.subjectCushing Diseaseen_US
dc.subjectNonfunctional Adenomasen_US
dc.subjectPituitary Adenomaen_US
dc.subjectProlactinomaen_US
dc.subjectTSHomaen_US
dc.titleEvaluation of Clinical, Laboratory and Treatment Modalities of Pituitary Adenomas: Single Center Experienceen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files